Temporal Course of Neointimal Formation After Drug-Eluting Stent Placement

被引:38
作者
Finn, Aloke V. [2 ]
Nakazawa, Gaku [1 ]
Kolodgie, Frank D. [1 ]
Virmani, Renu [1 ]
机构
[1] CVPath Inst Inc, Gaithersburg, MD 20878 USA
[2] Emory Univ, Atlanta, GA 30322 USA
关键词
drug-eluting stents; polymer-free; restenosis; late catch-up; CORONARY-ARTERY; FOLLOW-UP; IMPLANTATION; MODEL;
D O I
10.1016/j.jcin.2009.01.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:300 / 302
页数:3
相关论文
共 16 条
[1]   Durability of Antirestenotic Efficacy in Drug-Eluting Stents With and Without Permanent Polymer [J].
Byrne, Robert A. ;
Iijima, Raisuke ;
Mehilli, Julinda ;
Pinieck, Susanne ;
Bruskina, Olga ;
Schoemig, Albert ;
Kastrati, Adnan .
JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (04) :291-299
[2]   Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model [J].
Carter, AJ ;
Aggarwal, M ;
Kopia, GA ;
Tio, F ;
Tsao, PS ;
Kolata, R ;
Yeung, AC ;
Llanos, G ;
Dooley, L ;
Falotico, R .
CARDIOVASCULAR RESEARCH, 2004, 63 (04) :617-624
[3]   Vascular responses to drug eluting stents - Importance of delayed healing [J].
Finn, Aloke V. ;
Nakazawa, Gaku ;
Joner, Michael ;
Kolodgie, Frank D. ;
Mont, Erik K. ;
Gold, Herman K. ;
Virmani, Renu .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (07) :1500-1510
[4]   Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents [J].
Finn, AV ;
Kolodgie, FD ;
Harnek, J ;
Guerrero, LJ ;
Acampado, E ;
Tefera, K ;
Skorija, K ;
Weber, DK ;
Gold, HK ;
Virmani, R .
CIRCULATION, 2005, 112 (02) :270-278
[5]   Pathology of drug-eluting stents in humans - Delayed healing and late thrombotic risk [J].
Joner, Michael ;
Finn, Aloke V. ;
Farb, Andrew ;
Mont, Erik K. ;
Kolodgie, Frank D. ;
Ladich, Elena ;
Kutys, Robert ;
Skorija, Kristi ;
Gold, Herman K. ;
Virmani, Renu .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (01) :193-202
[6]   Three-year follow-up after implantation of metallic coronary-artery stents [J].
Kimura, T ;
Yokoi, H ;
Nakagawa, Y ;
Tamura, T ;
Kaburagi, S ;
Sawada, Y ;
Sato, Y ;
Yokoi, H ;
Hamasaki, N ;
Nosaka, H ;
Nobuyoshi, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (09) :561-566
[7]   Twenty-eight-day efficacy and phamacokinetics of the sirolimus-eluting stent [J].
Klugherz, BD ;
Llanos, G ;
Lieuallen, W ;
Kopia, GA ;
Papandreou, G ;
Narayan, P ;
Sasseen, B ;
Adelman, SJ ;
Falotico, R ;
Wilensky, RL .
CORONARY ARTERY DISEASE, 2002, 13 (03) :183-188
[8]  
LEON MB, 2006, TRANSC CARD THER ANN
[9]   Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery [J].
Moses, JW ;
Leon, MB ;
Popma, JJ ;
Fitzgerald, PJ ;
Holmes, DR ;
O'Shaughnessy, C ;
Caputo, RP ;
Kereiakes, DJ ;
Williams, DO ;
Teirstein, PS ;
Jaeger, JL ;
Kuntz, RE .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (14) :1315-1323
[10]  
Nakazawa Gaku, 2008, Expert Rev Cardiovasc Ther, V6, P1379, DOI 10.1586/14779072.6.10.1379